IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Q-Line Biotech Ltd.
Issue Open Date 21-May-26  
Issue Closing Date 25-May-26  
Application Money 100  
Allotment Money  
Price Band 326 - 343  
Minimium Application No. 800  
Issue Size (Shares) 4472000  
Market Lot 1.00  
Objective
1) To meet Working Capital requirements2) Repayment of certain borrowing availed by our Company, in part or full3) General Corporate Purpose.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     130466800   NA  
Qualified Institutional Buyers     147237200   NA  
Retail Individual Investors     148541600   NA  
Business Description
We are engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare
more...
Promoter's Holding
Total Share Capital   15750000  
Offered to Public   4472000  
Promoter's Holding (Pre-Issue)   96.77  
Promoter's Holding (Post-Issue)   67.51  
Address
298-281
Transport Nagar
Kanpur Road Adjacent Transport Nagar
Metro Station
Lucknow ,
Uttar Pradesh ,
226012
Phone: 0522 2435570
Email: compliance@qlinebiotech.com
Website: www.qlinebiotech.com
Registrar
Purva Shareregistry (India) Pvt Ltd
33 Printing House
28 D Police Court Lane
Behind Old Handloom House
Fort
Mumbai
Listed at
NSE
Lead Manager
Hem Securities Ltd.
Share India Capital Services Pvt Ltd.
Promoters
Abhay Agrawal
Ajay Kumar Mahanty
Amita Garg
Ayush Garg
Saurabh Garg
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.